Novozymes A/S
5.2.2021 20:18:36 CET | Globenewswire | Press release
Please read the full announcement in PDF
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ingredion Incorporated18.9.2026 00:05:21 CEST | Press release
Ingredion Incorporated Increases Quarterly Dividend to $0.83 Per Share
Biogen Inc.17.9.2026 22:15:00 CEST | Press release
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
Chint Global17.9.2026 21:05:04 CEST | Press release
CHINT Presents Advanced Grid Solutions for Europe in Paris
Scandinavian Investment Group A/S17.9.2026 20:52:10 CEST | Pressemeddelelse
Ledende medarbejders handel med aktier
F. Hoffmann-La Roche Ltd17.9.2026 20:30:00 CEST | Press release
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom